227 results on '"Domblides, Charlotte"'
Search Results
2. Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study
3. Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration
4. Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complications
5. Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
6. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
7. Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review
8. Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
9. Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives
10. Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target.
11. Current management and future perspectives of penile cancer: An updated review
12. Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve
13. MP15-13 CHARACTERIZATION OF THE IMMUNE INFILTRATION IN HIGH GRADE NMIBC: IMMUNVESSIE PROJECT
14. FGF amplification an important targeted for head and neck cancer patient? A case report of a patient with FGF amplification treated with erdafitinib
15. Human NLRC4 promotes cancer survival and is associated to type-I interferon signaling and immune infiltration
16. Real-World Efficacy of the Dabrafenib-Trametinib (D-T) Combination in Braf V600e-Mutated Metastatic Non-Small Cell Lung Cancer (Nsclc): Results from the Ifct-2004 Blade Cohort
17. Le Collège national des enseignants de cancérologie (CNEC) : missions, organisation et projets
18. Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis.
19. Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives
20. Treatment of spinal metastases in renal cell carcinoma: A critical review
21. Le cancer bronchopulmonaire chez les patients infectés par le VIH
22. Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice
23. Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
24. Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity
25. Immune checkpoint inhibitors and elderly people: A review
26. Crizotinib chez les patients atteints de cancer bronchopulmonaire ROS1 positifs
27. How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma.
28. Targeted therapy and elderly people: A review
29. Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives.
30. Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
31. Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
32. Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
33. Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates
34. An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
35. Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study
36. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
37. Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non–Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial
38. Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives
39. No impact of psychosocial stress on glioblastoma development
40. Clinical Impact of STK11 Mutation in Advanced-Stage Non-Small-Cell Lung Cancer
41. No Impact of Psychosocial Stress on Glioblastoma Development
42. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation
43. The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
44. Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital
45. Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma
46. Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2
47. Colitis presenting 5 months after the final dose of anti-PD-1: long-term monitoring is warranted after adjuvant therapy
48. Management of Immune Checkpoint Inhibitor Toxicities
49. Combination of trastuzumab, pertuzumab and docetaxel in patients with advanced non-small cell lung cancer (NSCLC) harboring HER2 mutation: Final results from the IFCT-1703 R2D2 trial.
50. The interest of sequential treatment with immune check point inhibitors followed chemotherapy: A case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.